Latest aortic aneurysm Stories
CHICAGO, April 27 /PRNewswire/ -- While repair of large abdominal aortic aneurysms (AAA's) is well accepted, randomized clinical trials have failed to demonstrate benefit for early surgical repair of small aneurysms over surveillance, according to researchers from New York-Presbyterian Hospital in New York. Details of their study appear in the May issue of the Journal of Vascular Surgery®, published by the Society for Vascular Surgery®. "Even though endovascular repair has been...
IRVINE, Calif., April 15 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its first quarter 2010 financial results, which will take place on Thursday, April 22, 2010 after the close of the market. Endologix will hold a conference call on Thursday, April 22, 2010 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for domestic...
IRVINE, Calif., April 14 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that the first patient has been enrolled in the Company's prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair ("EVAR"). The patient was treated at Oklahoma Heart Hospital by Jim G. Melton, DO. Dr. Melton said, "It is an honor to be the first...
LONDON, April 9, 2010 /PRNewswire/ -- - Trial Will Explore a More Individualized Endovascular Approach Targeting a Broader Patient Population for a Life-Threatening Condition that Affects 27 Million People Worldwide Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technologies, announced today that the first patients have been enrolled in the INNOVATION trial, which will assess the safety and performance of a new stent graft...
Case Western Reserve researchers find deficiency of Kruppel-like Factor 15 predicts cardiovascular diseasesCase Western Reserve University School of Medicine researchers have identified a major indicator of two deadly diseases of the heart and blood vessels: heart failure and aortic aneurysm. The absence of the Kruppel-like Factor 15 (KLF15), when combined with stress, leads to both heart failure and aortic aneurysms. The genetic factor, KLF15, protects the heart and aorta's ability to...
Variations associated with prevalence of medical condition rather than physician practice patterns or economicsWhile health policy researchers commonly suggest that geographic variations in the amount of medical care provided can be attributed to hospital costs or physician practice patterns, a new study examining regional utilization of a specific surgical procedure "“ minimally invasive aneurysm repair "“ shows that is not the case.Researchers at Cedars-Sinai Medical Center in Los...
IRVINE, Calif., Feb. 24 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the ROTH 22nd Annual OC Growth Stock Conference at The Ritz-Carlton Hotel in Laguna Niguel, CA. Event: ROTH 22nd Annual OC Growth Stock Conference Date: Monday, March 15, 2010 Time: 9:30 a.m. PT An audio Web cast...
IRVINE, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its fourth quarter and full year 2009 financial results, which will take place on Thursday, February 18, 2010 after the close of the market. Endologix will hold a conference call on Thursday, February 18, 2010 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877)...
One of first human implants of device for aortic injury in U.S. performed as part of clinical trialScott & White Memorial Hospital vascular surgeons Clifford Buckley, M.D., and Ruth Bush, M.D., performed one of the nation's first implants of a Next Generation Conformable GORE TAG Thoracic Endoprosthesis device for the treatment of a traumatic aortic transection as part of a national clinical trial. The goal of the trial is to gain insight into using thoracic endografts for patients with...
New research findings from a team at the Providence Heart + Lung Institute at St. Paul's Hospital and the University of British Columbia (UBC) may lead to new treatment options for abdominal aortic aneurysms (AAA) "“ a potentially fatal disease that currently has no pharmacological treatments.An aortic aneurysm is a bulging of the aorta, the largest blood vessel in the body. If the aneurysm ruptures, it causes rapid blood loss and a high risk of death. About 75 per cent of all aortic...
